Olema Pharmaceuticals Inc (OLMA) USD0.0001
1.59%- This stock can be held in a
Stocks and Shares ISASell:$9.96
Buy:$9.99
Change:
$0.20 (2.03%)
$0.20 (2.03%)Market closed | Prices delayed by at least 15 minutes
Sell:$9.96
Buy:$9.99
Change:$0.20 (2.03%)
$0.20 (2.03%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 28 March 2024 | Cyrus L. HarmonDirector | Sell Regular sell transaction (market) | 20,000 | $10.97 | $219,400.00 | 826,283 |
| 29 February 2024 | Cyrus L. HarmonDirector | Sell Regular sell transaction (market) | 24,900 | $12.41 | $309,009.00 | 846,383 |
| 29 February 2024 | Cyrus L. HarmonDirector | Sell Regular sell transaction (market) | 100 | $13.00 | $1,300.00 | 846,283 |
| 1 February 2024 | Cyrus L. HarmonDirector | Sell Regular sell transaction (market) | 5,000 | $15.56 | $77,800.00 | 871,283 |
| 31 January 2024 | Cyrus L. HarmonDirector | Sell Regular sell transaction (market) | 25,000 | $12.23 | $305,750.00 | 876,283 |
| 29 December 2023 | Cyrus L. HarmonDirector | Sell Regular sell transaction (market) | 22,500 | $13.30 | $299,250.00 | 903,783 |
| 29 December 2023 | Cyrus L. HarmonDirector | Sell Regular sell transaction (market) | 2,500 | $14.10 | $35,250.00 | 901,283 |
| 6 December 2023 | PARADIGM BIOCAPITAL ADVISORS LPInvestment Management Company | Buy Regular purchase transaction | 100,000 | $11.60 | $1,160,000.00 | 6,590,981 |
| 5 December 2023 | LOGOS OPPORTUNITIES FUND I LPHedge Fund | Buy Regular purchase transaction | 50,000 | $13.09 | $654,250.00 | 1,800,000 |
| 5 December 2023 | LOGOS OPPORTUNITIES FUND I LPHedge Fund | Buy Regular purchase transaction | 50,000 | $14.95 | $747,480.00 | 1,750,000 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 12 September 2023 | BVF PARTNERS LPPrivate Equity | Buy Regular purchase transaction | 775,278 | $9.84 | $7,628,735.52 | 4,688,954 |
| 12 September 2023 | BVF PARTNERS LPPrivate Equity | Buy Regular purchase transaction | 677,853 | $9.84 | $6,670,073.52 | 3,584,512 |
| 12 September 2023 | LOGOS OPPORTUNITIES FUND I LPHedge Fund | Buy Regular purchase transaction | 508,130 | $9.84 | $4,999,999.20 | 1,668,130 |
| 6 December 2023 | PARADIGM BIOCAPITAL ADVISORS LPInvestment Management Company | Buy Regular purchase transaction | 100,000 | $11.60 | $1,160,000.00 | 6,590,981 |
| 5 December 2023 | LOGOS OPPORTUNITIES FUND I LPHedge Fund | Buy Regular purchase transaction | 50,000 | $14.95 | $747,480.00 | 1,750,000 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.